Skip to main content

Advertisement

Log in

Biliary Atresia and Cytomegalovirus and Response to Valganciclovir

  • Case Reports
  • Published:
Indian Pediatrics Aims and scope Submit manuscript

Biliary atresia has been commonly reported with cytomegalovirus (CMV) infection. CMV positive patients may present with a later onset however long term outcome is similar to non-CMV patients. There are very few case reports of role of antivirals in CMV and biliary atresia. We treated a 2 month old girl with biliary atresia who underwent portoduodenostomy at 2½ months of age but continued to have jaundice (bilirubin = 23.6 mg/dl) even after 1 month of Kasai’s surgery and subsequently was treated with valganciclovir for 6 weeks following which her jaundice resolved.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Zukotynski K, Babyn PS. Biliary Atresia. Available from: http://www.emedicine.com. Accessed on 5 February, 2010.

  2. Fischler B, Svensson JF, Nemeth A. Early cytomegalovirus infection and the long-term outcome of biliary atresia. Acta Paediatr. 2009;98:1600–1602.

    Article  PubMed  Google Scholar 

  3. Rauschenfels S, Krassmann M, Al-Masri AN, Verhagen W, Leonhardt J, Kuebler JF, et al. Incidence of hepatotropic viruses in biliary atresia. Eur J Pediatr. 2009;168:469–476.

    Article  PubMed  Google Scholar 

  4. Sanghai S, Shah I, Bhatnagar S, Murthy A. incidence and prognostic factors associated with biliary atresia in western India. Annals Hepatol. 2009;8:120–122.

    Google Scholar 

  5. Miiler A, Eis-Hubinger AM, Brandhorst G, Heep A, Bartmann P, Franz AR. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol. 2008;28:74–76.

    Article  Google Scholar 

  6. Fischler B, Casswall TH, Malmborg P, Nemeth A. Ganciclovir treatment in infants with cytomegalovirus infection and cholestasis. J Pediatr Gastroenterol Nutr. 2002;34:154–157.

    Article  PubMed  CAS  Google Scholar 

  7. Tezer H, Secmeer G, Kara A, Ceyhan M, Cengiz AB, Devrim I, et al. Cytomegalovirus hepatitis and ganciclovir treatment in immunocompetent children. Turk J Pediatr. 2008;50:228–234.

    PubMed  Google Scholar 

  8. Fischler B, Wozenius S, Nemeth A, Papadogiannakis N. Immunoglobulin deposits in liver tissue from infants with biliary atresia and the correlation to cytomegalovirus infection. J Pediatr Surg. 2005;40:541–546.

    Article  PubMed  Google Scholar 

  9. Ozkan TB, Mistik R, Dikici B, Nazlioglu HD. Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis. BMC Gastroenterol. 2007;7:9.

    Article  PubMed  Google Scholar 

  10. Chang MH, Huang HH, Huang ES, Kao CL, Hsu HY, Lee CY. Polymerase chain reaction to detect human cytomegalovirus in livers of infants with neonatal hepatitis. Gastroenterology. 1992;103:1022–1025.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ira Shah.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shah, I., Bhatnagar, S. Biliary Atresia and Cytomegalovirus and Response to Valganciclovir. Indian Pediatr 49, 484–486 (2012). https://doi.org/10.1007/s13312-012-0092-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13312-012-0092-7

Key words

Navigation